KR20020002033A - 혈관신생 억제제 - Google Patents
혈관신생 억제제 Download PDFInfo
- Publication number
- KR20020002033A KR20020002033A KR1020000036452A KR20000036452A KR20020002033A KR 20020002033 A KR20020002033 A KR 20020002033A KR 1020000036452 A KR1020000036452 A KR 1020000036452A KR 20000036452 A KR20000036452 A KR 20000036452A KR 20020002033 A KR20020002033 A KR 20020002033A
- Authority
- KR
- South Korea
- Prior art keywords
- arsenic
- angiogenesis
- cells
- present
- hexaoxide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/36—Arsenic; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (2)
- 육산화사비소로 이루어지는 것을 특징으로 하는 혈관신생 억제제.
- 육산화사비소를 함유하는 것을 특징으로 하는 혈관신생 억제능을 갖는 약제학적 조성물.
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2000-0036452A KR100399657B1 (ko) | 2000-06-29 | 2000-06-29 | 혈관신생 억제제 |
TW090106766A TW518227B (en) | 2000-06-29 | 2001-03-22 | Angiogenesis inhibitor |
CA002342059A CA2342059A1 (en) | 2000-06-29 | 2001-03-26 | Angiogenesis inhibitor |
CN01110419A CN1329891A (zh) | 2000-06-29 | 2001-04-03 | 血管生成抑制剂 |
US09/824,879 US6703049B2 (en) | 2000-06-29 | 2001-04-04 | Angiogenesis inhibitor |
EP01303190A EP1166789A3 (en) | 2000-06-29 | 2001-04-04 | Arsenolite containing angiogenesis inhibitor |
JP2001163710A JP2002029976A (ja) | 2000-06-29 | 2001-05-31 | 血管新生抑制剤 |
RU2001118219/14A RU2001118219A (ru) | 2000-06-29 | 2001-06-28 | Ингибитор ангиогенеза |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2000-0036452A KR100399657B1 (ko) | 2000-06-29 | 2000-06-29 | 혈관신생 억제제 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20020002033A true KR20020002033A (ko) | 2002-01-09 |
KR100399657B1 KR100399657B1 (ko) | 2003-09-29 |
Family
ID=36458402
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2000-0036452A KR100399657B1 (ko) | 2000-06-29 | 2000-06-29 | 혈관신생 억제제 |
Country Status (8)
Country | Link |
---|---|
US (1) | US6703049B2 (ko) |
EP (1) | EP1166789A3 (ko) |
JP (1) | JP2002029976A (ko) |
KR (1) | KR100399657B1 (ko) |
CN (1) | CN1329891A (ko) |
CA (1) | CA2342059A1 (ko) |
RU (1) | RU2001118219A (ko) |
TW (1) | TW518227B (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100483195B1 (ko) * | 2002-08-12 | 2005-04-14 | 배일주 | 육산화사비소를 유효성분으로 함유하는 사상충증예방·치료용 약제학적 조성물 |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101100786B1 (ko) * | 2008-12-16 | 2011-12-29 | (주)천지산 | 암에 대한 방사선 치료 증진용 조성물 |
KR101119587B1 (ko) | 2011-03-10 | 2012-04-17 | 배일주 | 육산화사비소를 함유하는 용출률 및 안정성이 개선된 경구투여형 약제학적 제제 |
CN105200534A (zh) * | 2015-10-23 | 2015-12-30 | 安徽理工大学 | 一种新型静电纺丝溶液的配比方法及其制备过程 |
CN108066359A (zh) * | 2016-11-09 | 2018-05-25 | 凯马斯株式会社 | 包含六氧化四砷的用于抑制癌转移的药物组合物 |
KR101755556B1 (ko) * | 2016-11-18 | 2017-07-07 | 주식회사 케마스 | 육산화사비소의 결정다형을 포함하는 뇌암 예방 또는 치료용 약학 조성물 및 이의 제조방법 |
KR101834366B1 (ko) * | 2016-11-21 | 2018-03-05 | 주식회사 케마스 | 육산화사비소의 결정다형을 포함하는 유방암 예방 또는 치료용 약학 조성물 및 이의 제조방법 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1231922A (en) * | 1915-11-26 | 1917-07-03 | Western Electric Co | Telephone-exchange system. |
JP2766669B2 (ja) * | 1989-06-06 | 1998-06-18 | 曙ブレーキ工業株式会社 | 車両の発進防止装置 |
BR9814857A (pt) * | 1997-11-10 | 2001-12-26 | Sloan Kettering Inst Cancer | Processos para tratar leucemia, câncer sólido eleucemia, linfoma ou tumores sólidos em umhumano, e para fabricar uma composiçãofarmacêutica estéril, e, a respectiva composiçãofarmacêutica estéril |
KR100272835B1 (ko) * | 1998-05-08 | 2000-11-15 | 배일주 | 천연 화학물질 육산화사비소의 신규한 항종양 치료제로서의 용도 및 그 약학적 조성물 |
FR2782010A1 (fr) | 1998-08-06 | 2000-02-11 | Inst Vaisseaux Et Du Sang | Nouvelle utilisation d'un compose d'arsenic vis-a-vis de la leucemie megacaryocytaire ou plaquettaire |
FR2786103A1 (fr) | 1998-10-30 | 2000-05-26 | Assist Publ Hopitaux De Paris | Utilisation de trioxyde d'arsenic pour la preparation d'un medicament destine a traiter les affections neoplastiques du tissu hematopoietique chez un mammifere et nouvelle composition pharmaceutique |
-
2000
- 2000-06-29 KR KR10-2000-0036452A patent/KR100399657B1/ko active IP Right Grant
-
2001
- 2001-03-22 TW TW090106766A patent/TW518227B/zh not_active IP Right Cessation
- 2001-03-26 CA CA002342059A patent/CA2342059A1/en not_active Abandoned
- 2001-04-03 CN CN01110419A patent/CN1329891A/zh active Pending
- 2001-04-04 US US09/824,879 patent/US6703049B2/en not_active Expired - Lifetime
- 2001-04-04 EP EP01303190A patent/EP1166789A3/en not_active Withdrawn
- 2001-05-31 JP JP2001163710A patent/JP2002029976A/ja active Pending
- 2001-06-28 RU RU2001118219/14A patent/RU2001118219A/ru not_active Application Discontinuation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100483195B1 (ko) * | 2002-08-12 | 2005-04-14 | 배일주 | 육산화사비소를 유효성분으로 함유하는 사상충증예방·치료용 약제학적 조성물 |
Also Published As
Publication number | Publication date |
---|---|
CA2342059A1 (en) | 2001-12-29 |
CN1329891A (zh) | 2002-01-09 |
TW518227B (en) | 2003-01-21 |
EP1166789A3 (en) | 2003-10-22 |
US20020001630A1 (en) | 2002-01-03 |
JP2002029976A (ja) | 2002-01-29 |
KR100399657B1 (ko) | 2003-09-29 |
RU2001118219A (ru) | 2003-04-20 |
US6703049B2 (en) | 2004-03-09 |
EP1166789A2 (en) | 2002-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5428011A (en) | Pharmaceutical preparations for inhibiting tumours associated with prostate adenocarcinoma | |
US4708948A (en) | Substantially purified tumor growth inhibitory factor | |
KR100399657B1 (ko) | 혈관신생 억제제 | |
EP0179477A2 (en) | Fibronectin preparations | |
Bachleitner-Hofmann et al. | Arsenic trioxide: acute promyelocytic leukemia and beyond | |
JPH06509791A (ja) | 血管形成抑制のための方法と組成物 | |
EP0869809B1 (en) | Oxidized glutathione as cytokine and hemopoietic factor endogenous production enhancer | |
Kim et al. | The inhibitory effects of recombinant plasminogen kringle 1-3 on the neovascularization of rabbit cornea induced by angiogenin, bFGF, and VEGF | |
EP3666791B1 (en) | Modified fibroblast growth factors-1 for the treatment of ocular disorders | |
Loughnan et al. | Experimental corneal neovascularisation using sucralfate and basic fibroblast growth factor | |
Bersani et al. | Involvement of tumour necrosis factor in monocyte-mediated rapid killing of actinomycin D-pretreated WEHI 164 sarcoma cells. | |
Park et al. | Tetraarsenic oxide, a novel orally administrable angiogenesis inhibitor | |
CA2033249C (en) | Cytostatic or cytotoxic combination of active substances for use in therapeutic procedures | |
Bode et al. | Apoptosis induction by arsenic: mechanisms of action and possible clinical applications for treating therapy-resistant cancers | |
US20060172940A1 (en) | Antimicrobial agent | |
US20140199407A1 (en) | Palladium-ruthenium-zinc-organo complexes and methods for their use in the treatment of inflammatory diseases | |
US7012062B2 (en) | Use of modified lysozyme C to prepare medicinal compositions for the treatment of some serious diseases | |
Stadler et al. | Long-term combined rIFN-alpha-2a and zidovudine therapy for HIV-associated Kaposi's sarcoma: clinical consequences and side effects | |
JPH0625010A (ja) | 抗ガン剤 | |
US20030027770A1 (en) | Cytokine and hemopoietic factor endogenous production enhancer and methods of use thereof | |
KR960013439B1 (ko) | 안정한 상피세포 성장인자(egf) 조성물 | |
KR100450578B1 (ko) | 엔엠23 단백질을 유효성분으로 하는, 매트릭스메탈로프로테아제 활성 억제 및 혈관신생 억제용 조성물 | |
US5849282A (en) | Method of treating colon, renal, and lung carcinomas with γ-interferon and Ser71 !-interleukin-1β | |
KR20030075017A (ko) | 삼산화비소를 포함하는 혈관신생억제제 | |
Grupe | Childhood nephrotic syndrome: clinical associations and response to therapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
AMND | Amendment | ||
J201 | Request for trial against refusal decision | ||
E902 | Notification of reason for refusal | ||
B701 | Decision to grant | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20120911 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20130923 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20140916 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20150918 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20170830 Year of fee payment: 15 |
|
FPAY | Annual fee payment |
Payment date: 20180912 Year of fee payment: 16 |